Olugemo Olukemi 4
4 · Korro Bio, Inc. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Korro Bio, Inc.KRRO
Olugemo Olukemi
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-03+65,000→ 65,000 totalExercise: $50.48Exp: 2034-06-02→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as to 25% of the shares on May 13, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.